Together, BIOTECanada and Canada’s Drug Agency (CDA-AMC) developed and tested a strategic foresight framework, offering key recommendations to guide the health system as it navigates the introduction of Advanced Therapeutic Products (ATPs). BIOTECanada members valued the opportunity to work with CDA-AMC to support system readiness for ATPs in Canada; this project represents a significant milestone in the collaboration between CDA-AMC and industry.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biotech.ca/news/building-a-strategic-foresight-framework-to-support-system-readiness-for-advancedtherapeutic-products-in-canada/